<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">Only patients with respiratory specimens collected within 7 days of symptom onset were included to reduce false negatives due to decreasing viral RNA levels over time [
 <xref ref-type="bibr" rid="CR8">8</xref>]. Sites including fewer than 40 hospitalized patients were excluded from the current analysis to reduce variability. For each site, the inclusion period was defined by the weeks with positive specimens for influenza. Patients enrolled outside the inclusion period at each site were excluded from analysis. The co-primary endpoints were (a) the proportion of influenza-positive patients with “complicated hospitalization”, as defined by a need for mechanical ventilation support, admission to an ICU, or death during hospitalization; and (b) length of hospital stay in days. Age categories were as recommended by the World Health Organization for analysis of severe acute respiratory illness/influenza-like illness [
 <xref ref-type="bibr" rid="CR13">13</xref>].
</p>
